|
Market Closed -
Euronext Bruxelles
20:55:00 29/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.002000 EUR | 0.00% |
|
0.00% | -13.04% |
| 09-24 | BioSenic S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 28/10/25 | BioSenic S.A. Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.46M | - | - | - | - | - |
| 1,148B | |||||
| 652B | |||||
| 505B | |||||
| 384B | |||||
| 348B |
- Stock Market
- Stocks
- BIOS Stock
- Charts BioSenic SA
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
